Directly compressible materials via co-processing

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 745-753

  Patel, Rakesh P ^a   Bhavsar, Ms Mansi ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; NUTRACEUTICAL; PARACETAMOL; VITAMIN;

CHEMICAL MODIFICATION; COST EFFECTIVENESS ANALYSIS; DILUTION; DRUG DELIVERY SYSTEM; EQUIPMENT; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; REVIEW; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; VELOCITY; WETTABILITY;

EID: 77953464705     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Czelsler, J. L., and Perlman, K.P. (1990), "Diluents," in Encyclopaedia of Pharmaceutical Technology, Swarbrick J and Boylan J.C., Eds. (Marcel Dekker, Inc., New York, NY), pp. 37-83.
2. Rasenack, N., and Muller, B. W. (2002), Crystal Habit and Tableting Behaviour, Int. J. Pharm., 244: 45-57.
3. Sam, A. P., and Fokkens, J. G. (1997), Drug Delivery System: Adding Therapeutic and Economic Value to Pharmacotherapy. Part 2, Pharm. Tech. Eur., 9:58-66.
4. Armstrong, N. A. (1989), Selection of excipients for direct compression tablet formulation, Pharm. Technol. Eur., 9: 24-30, Armstrong N.A. and Palfrey L.P., "The Effect of Machine Speed on the Consolidation of Four Directly Compressible Tablet Diluents," J. Pharm. Pharmacology. 41, 149-151.
5. Jivraj, M., Martini, L. G., and Thomson, C. M. (2000), an Overview of the Different Excipients Useful for the Direct Compression of Tablets, PSTT, 3: 58-63,.
6. Smewing, J. (2002), Powder flow analysis- the solution, Manuf. Chem., 32-33.
7. www.expresspharmaonline.com/20040226/technol ogytrendz01.shtml
8. nd ed., 85-160.
9. Banker, U. V. (1994), Role of Ingredients and Excipients in Developing Pharmaceuticals, Manuf. Chem., 65: 32- 34.
10. st ed., 304- 321.
11. Ibrahim, Y. K., and Olurinola, P. F. (1991), Comparative Microbial Contamination Levels in Wet Granulation and Direct Compression Methods of Tablet Production, Pharm. Acta. Helv. 66: 298-301.
12. Shangraw, R. F., Wallace, J. W., and Bowers, F. M. (1987), Morphology and Functionality in Tablet Excipients for Direct Compression, Pharm. Technol., 11: 136- 143.
13. Steinberg M., Blecher L., and Mercill A. (2001), "From Inactive Ingredients to Pharmaceutical Excipients," Pharm. Technol. 25 (7), 62-64.
14. Moreton R.C. (1996), "Tablet Excipients to the Year 2001: A Look into the Crystal Ball," Drug Dev. Ind. Pharm. 22 (1), 11-23.
15. Bansal, A.K., and Nachaegari S.K. (2002), "High Functionality Excipients for Solid Oral Dosage Forms," in Business Briefings: Pharmagenerics (World Markets Research Centre, London, UK) pp. 38-44.
16. CyDex, "Innovative Drug Delivery Technologies," www.captisol.com
17. Shangraw, R.F., and Wallace, J.W. (1981), "Morphology and Functionality in Tablet Excipients for Direct Compression: Part I," Pharm. Technol. 5 (9), 69-78.
18. Shangraw, R.F. (1997), "Emerging Trends in the Use of Pharmaceutical Excipients," Pharm. Technol. 21 (6), 36-42.
19. Russell, R. (2004), Synthetic Excipients Challenge All-Natural Organics -Offer advantages/ Challenges to Developers and Formulators, Pharm. Technol., 27: 38 - 50.
20. Reimerdes (1993), "The Near Future of Tablet Excipients, "ManufacturingChemist, 64 (7), 14-15.
21. Reimerdes, D., and Aufmuth, K. P. (1992), Tabletting with Co-processed Lactose-Cellulose Excipients, Manuf. Chem. 63: 21-24.
22. Tobyn, M.J. (1998), "Physicochemical Comparison between Microcrystalline Cellulose and Silicified Microcrystalline Cellulose," Int. J. Pharm. 169, 183-194. [23] York, P. (1992), "Crystal Engineering and Particle Design for the Powder Compaction Process," Drug Dev. Ind. Pharm. 18 (6,7), 677-721.
23. Belda, P. M. and Mielck, J. B. (1996). "The Tableting Behaviour of Cellactose Compared with Mixtures of Celluloses with Lactose," Eur. J. Pharm.Biopharm. 42 (5), 325-330.
24. Sherwood, B.E. and Becker, J.W. (1988), "A New Class of High Functionality Excipients: Silicified Microcrystalline Cellulose," Pharm. Technol. 22(10), 78-88.
25. Allen, J. D. (1997), "Improving DC with SMCC,"Manufacturing Chemist 67 (12), 19-20, 23.
26. Schmidt, P.C. and Rubensdorfer, C. J. W. (1994), "Evaluation of Ludipress as a Multipurpose Excipient for Direct Compression Part I: Powder Characteristics and Tableting Properties," Drug Dev. Ind. Pharm. 20 (18), 2899-2925.
27. Flores, L.E, Arellano, R.L., and Esquivel, J.J.D. (2000), "Study of Load Capacity of Avicel PH-200 and Cellactose, Two Direct-Compression Excipients, Using Experimental Design," Drug Dev. Ind. Pharm. 26 (4), 465-469.
28. Gohel, M. C., Jogani, P. D., Bariya S. H. (2003) , "Development of Agglomerated Directly Compressible Diluent Consisting of Brittle and Ductile Materials" Pharmaceutical Development and Technology, 8(2), 143 - 151.
29. Modliszewski, J. J. and Ballard, D.A. (1996), "Coprocessed Galctomannan-Glucomannan," US Patent No. 5,498,436 to FMC Corporation (Philadelphia, PA).
30. nd Ed, 195-246.
31. Bolhius, G. K., and Chowhan, Z. T. (1996), Materials for Direct Compression, Pharmaceutical Powder Compaction Technology, Vol-7, Marcel Dekker, USA, 419-499, 20 [11].
32. Zeleznik, J. A., and Renak, J. (2004), "High Functionality Excipients (HFE) -PROSOLV® SMCC as an Effective Strategy for Generic Drug Formulation" Business briefing: Pharmagenerics.
33. Moreton, R.C., "Cellulose, Silicified Microcrystalline," in Hand Book of Pharmaceutical Excipients, Wade V and Weller P.J., Eds. (Pharmaceutical Press, London), pp. 110-111.
34. Dev, K. M. (1988), "Co-proceseed Microcrystalline Cellulose and Calcium Carbonate and Its Preparation," US Patent No. 4,744,987 to FMC Corporation (Philadelphia, PA).
35. European Pharmaceutical Manufacturer Magazine "Cellactose 80 Filler Blender" Vol 2, Issue 8 (http://www.pharmeurope.com/x/guideArchiveArticle. html?id=1038)
36. Plaizier-Vercammen, J. A., and Bossche V. D. (1993), Evaluation of the Tableting Properties of a New Excipient for Direct Compression, Drugs Made in Germany, 36: 133-137.
37. Prosolv Technical Report: Tableting Binder Improves Production (Pen west Pharmaceuticals, New York, NY) (2001).